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bronchiectasisSir,In our cohort of 397 adults with cystic fibrosis (CF) who
had genotyping for the CF mutations, the R117H mutation
was found in only 3 patients, all with late diagnosis of CF
after the age of 18. Two of these patients have been
described previously [1]. The third one had the R117H
and W1282X mutations, an intermediate sweat test (sweat
chloride: 54 mmol/l) and was pancreatic sufficient. He had
benefited from assisted reproductive techniques because of
congenital bilateral absence of the vas deferens and had
been diagnosed as CF at the age of 34 because of acute
pulmonary infection with Staphylococcus aureus and Pseu-
domonas aeruginosa. He had no diffuse bronchiectasis and
his FEV1 was 103% predicted.
When classifying CFTR genotypes into three groups
(mild, severe or indeterminate CFTR genotype) according
to the probable effect of their mutations on CFTR function
[2], we found mild genotype was much more frequent in the
74 CF adults diagnosed in adulthood than in the 323 CF
adults diagnosed before the age of 18 ( p < 0.001). The
repartition of CFTR genotype was the following, respec-
tively, for late versus early diagnosis of CF: mild genotype
in 46 patients (62%) vs. 48 (15%), severe genotype in 16
patients (22%) vs. 252 (78%) and indeterminate genotype in
12 patients (16%) vs. 23 (7%). Like McCloskey et al. [3],
we found that delayed diagnosis was associated with pan-
creatic sufficiency.
We agree with Dr Martin Kelly that the differences
observed between the Northern Irish and French popula-
tions for the R117H mutation reflect geographical variation
distribution. R117H has significantly higher frequencies in1569-1993/$ - see front matter D 2004 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2004.06.004Northern Irish, where it represents 4.1% of CF chromo-
somes [4], than in the rest of Northern Europe (0.15% in
France) [5]. However, we found a high incidence of
various mild mutations in our CF population diagnosed
in adulthood.References
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